Egle Solito currently works at the William Harvey Research Institute, SMD, Queen Mary University of London-UK. Egle's team research is centered on the impact of inflammation, metabolism and ageing at the intersection between the immune system and the blood-brain barrier. The lab study diseases such as Multiple Sclerosis, Alzheimer and Diabetes. The lab use in vivo approach on animal model as well as ex vivo and in vitro model (murine and human) of BBB.